Eli Lilly: Endowment proposes $369M share sale

The notice also lists four common-stock sales by Lilly Endowment during the preceding three months.

Rhea-AI Filing Summary

Eli Lilly and Company (LLY) shareholder Lilly Endowment, Inc. reported a proposed sale of 305,000 common shares through Fidelity Capital Markets, with an aggregate market value of $368,665,700 and an approximate sale date of October 15, 2026. The notice lists 941,357,065 shares outstanding and was signed by Diane M. Stenson, Vice President and Treasurer.

Key Figures

Common shares proposed for sale: 305,000 shares Aggregate market value: $368,665,700 Shares outstanding: 941,357,065 shares +1 more

4 metrics

Common shares proposed for sale 305,000 shares Approximate sale date October 15, 2026

Aggregate market value $368,665,700 Proposed sale of common shares

Shares outstanding 941,357,065 shares Common stock listed in the notice

Approximate sale date October 15, 2026 Proposed common-stock sale

Key Terms

Rule 144, aggregated, person for whose account the securities are to be sold

3 terms

Rule 144 regulatory

"sales are required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

aggregated regulatory

"sales are required by paragraph (e) of Rule 144 to be aggregated"

person for whose account the securities are to be sold regulatory

"Name of Person for Whose Account the Securities are To Be Sold"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many LLY shares is Lilly Endowment proposing to sell?

Lilly Endowment, Inc. is listed as proposing to sell 305,000 shares of Eli Lilly and Company common stock through Fidelity Capital Markets, with an approximate sale date of October 15, 2026.

What value does the notice assign to Lilly Endowment's proposed LLY sale?

The notice lists an aggregate market value of $368,665,700 for the 305,000 common shares proposed for sale by Lilly Endowment, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/15/2026 - 02:44 PM EDT Accepted by SEC EDGAR 10/15/2026 - 02:44 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000316011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ELI LILLY AND COMPANY
SEC File Number	001-06351
Address of Issuer	LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS INDIANA 46285
Phone	317-276-2000
Name of Person for Whose Account the Securities are To Be Sold	LILLY ENDOWMENT, INC.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Shareholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Fidelity Capital Markets 640 Fifth Avenue New York NY 10019	305000	368665700	941357065	10/15/2026	NYSE, NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	02/10/1948	Gift	J.K. Lilly Sr. Trust		01/21/1937	38400000		N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	08/13/2026	122	151280
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	08/19/2026	302403	385708676.04
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/07/2026	28357	34117815.29
Lilly Endowment Inc. 2801 North Meridian Street Indianapolis IN 46208	Eli Lilly and Company Common Stock	10/14/2026	271643	328823634.19

144: Remarks and Signature

Remarks
Date of Notice	10/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Diane M. Stenson, Vice President and Treasurer
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)